Oliver Hendricks

A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry

Bente Glintborg, Inge Juul Sørensen, Anne Gitte Loft et al. · Annals of the Rheumatic Diseases · 2017 · 245 citations

To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry

Bente Glintborg, Anne Gitte Loft, Emina Omerovic et al. · Annals of the Rheumatic Diseases · 2018 · 153 citations · Full text

Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial

Merete Lund Hetland, Espen A. Haavardsholm, Anna Rudin et al. · BMJ · 2020 · 108 citations · Full text

Effect of Magnetic Resonance Imaging vs Conventional Treat-to-Target Strategies on Disease Activity Remission and Radiographic Progression in Rheumatoid Arthritis

Signe Møller-Bisgaard, Kim Hørslev‐Petersen, Bo Ejbjerg et al. · JAMA · 2019 · 88 citations · Full text

Associations Between Spondyloarthritis Features and Magnetic Resonance Imaging Findings: A Cross‐Sectional Analysis of 1,020 Patients With Persistent Low Back Pain

Bodil Arnbak, Anne Grethe Jurik, Kim Hørslev‐Petersen et al. · Arthritis & Rheumatology · 2015 · 84 citations